Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Channing J Der

Showing results (171-180 of 236) with videos related to

Pageof 24
Sort By:
Molecular Cancer Therapeutics|April 18, 2009
KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancerJen Jen Yeh, Elizabeth D Routh, Tara Rubinas, et al.
NAR Cancer|March 21, 2025
TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stressJay R Anand, Gaith N Droby, Sayali Joseph, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2005
Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndromeBrian C Capell, Michael R Erdos, James P Madigan, et al.
The Biochemical Journal|September 3, 2009
Regulation of Rnd3 localization and function by protein kinase C alpha-mediated phosphorylationJames P Madigan, Brian O Bodemann, Donita C Brady, et al.
Molecular and Cellular Biology|October 22, 2014
Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligaseTai Young Kim, Priscila F Siesser, Kent L Rossman, et al.
Cancer Letters|June 10, 2021
KRAS-dependent cancer cells promote survival by producing exosomes enriched in SurvivinWen-Hsuan Chang, Thuy-Tien Thi Nguyen, Chia-Hsin Hsu, et al.
Molecular Oncology|March 24, 2021
Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screenAnna Barkovskaya, Craig M Goodwin, Kotryna Seip, et al.
Cancer Discovery|January 1, 2013
Mutant N-RAS protects colorectal cancer cells from stress-induced apoptosis and contributes to cancer development and progressionYufang Wang, Sérgia Velho, Efsevia Vakiani, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2020
Analysis of RAS protein interactions in living cells reveals a mechanism for pan-RAS depletion by membrane-targeted RAS bindersYao-Cheng Li, Nikki K Lytle, Seth T Gammon, et al.
Scientific Reports|June 25, 2020
Genome-wide DNA methylation analysis of KRAS mutant cell linesBen Yi Tew, Joel K Durand, Kirsten L Bryant, et al.
Pageof 24

Showing results (171-180 of 236) with videos related to

Sort By:
Pageof 24
Molecular Cancer Therapeutics|April 18, 2009
KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancerJen Jen Yeh, Elizabeth D Routh, Tara Rubinas, et al.
NAR Cancer|March 21, 2025
TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stressJay R Anand, Gaith N Droby, Sayali Joseph, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2005
Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndromeBrian C Capell, Michael R Erdos, James P Madigan, et al.
The Biochemical Journal|September 3, 2009
Regulation of Rnd3 localization and function by protein kinase C alpha-mediated phosphorylationJames P Madigan, Brian O Bodemann, Donita C Brady, et al.
Molecular and Cellular Biology|October 22, 2014
Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligaseTai Young Kim, Priscila F Siesser, Kent L Rossman, et al.
Cancer Letters|June 10, 2021
KRAS-dependent cancer cells promote survival by producing exosomes enriched in SurvivinWen-Hsuan Chang, Thuy-Tien Thi Nguyen, Chia-Hsin Hsu, et al.
Molecular Oncology|March 24, 2021
Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screenAnna Barkovskaya, Craig M Goodwin, Kotryna Seip, et al.
Cancer Discovery|January 1, 2013
Mutant N-RAS protects colorectal cancer cells from stress-induced apoptosis and contributes to cancer development and progressionYufang Wang, Sérgia Velho, Efsevia Vakiani, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2020
Analysis of RAS protein interactions in living cells reveals a mechanism for pan-RAS depletion by membrane-targeted RAS bindersYao-Cheng Li, Nikki K Lytle, Seth T Gammon, et al.
Scientific Reports|June 25, 2020
Genome-wide DNA methylation analysis of KRAS mutant cell linesBen Yi Tew, Joel K Durand, Kirsten L Bryant, et al.
Pageof 24